The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
Cmb.Tech NV
CMBT · the NYSE · USD · Market cap $5.1B
FAIL · Does not pass the screenPrice as of 18 Nov 2026Daily close, not a live quote
Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price16.62 USD at the 18 Nov 2026 close
- Our value readFair vs our fair value, as of 18 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.39)
- Last reviewed18 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $14.49 to $19.70, base estimate $17.13 (screen dated 2026-11-18).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.39, read 2026-11-19
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Cmb.Tech NV holds its Distribution at $16.62. Consolidating, no directional conviction, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $16.62 |
| Valuation | 5.92 trailing · 11.37 forward price to earnings |
| Values screen | FAIL |
| Beta | 0.14 |
Five Screens: CMBT's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 128.02% | Below 33% | Fail |
| Interest-bearing cash | 3.38% | Below 33% | Pass |
| Receivables | 0.00% | Below 49% | Pass |
| Revenue purity | 0.39% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Cmb.Tech's business is in a permissible area, but its interest-bearing debt is about 128% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CMBT's ethical verdict changes
Today CMBT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 18 Nov 2026: it trades at roughly a 3% discount to our $17.13 fair value, weak competitive moat, 81.50% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. A 3.0% discount to the base estimate.
Third-party analyst targets. The average target sits +28% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $17.13, with a range of $14.49 to $19.70, dated to the 2026-11-18 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsEnergy shipper looks cheap but carries heavy baggage
Picture a fleet of tankers chasing oil-price spikes one year and idling the next. CMB.Tech shows 121% revenue growth and a 25% profit margin, yet we pass. The forward multiple sits at just 10x and fair value offers only a slim buffer above the current price, but the business sits in a deeply cyclical trade where peak earnings often produce exactly this kind of low multiple.
The ethical screen fails on debt levels and the moat is rated weak, so even the 17% ROE does not compensate. Four analysts see a median target of $20, yet that optimism rests on the same commodity cycle that has crushed similar operators in past downturns.
High leverage leaves little room when rates or volumes turn, and the value-trap warning is clear: a low multiple on peak earnings is rarely a bargain. Analysis, not advice.
| Forward P/E | 11.4xcheap for a company growing this fast |
| Trailing P/E | 5.9xvery cheap relative to earnings |
| EPS, trailing | 2.96 |
| EPS, forward | 1.54 |
| Revenue growth | +81.5%growing very fast |
| Profit margin | 37.2%highly profitable on every dollar of sales |
| Return on equity | 29.6%an exceptional return on shareholder capital |
| FCF yield | -15.91% |
| Dividend yield | 7.46% |
| Debt to equity | 1.75a meaningful debt load worth watching |
| Current ratio | 1.12adequate liquidity, worth monitoring |
| Beta | 0.14barely tracks the market's swings |
| Short interest, float | 0.03% |
| 52-week range | 9.37 - 21.19 |
| Moat | WEAK |
| Market cap | $5.1B |
CMBT-specific watchpoints · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 15.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 21.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- CMB.TECH ANNOUNCES Q3 2026 RESULTS ON 26/11/2026 Yahoo Finance · 8d ago
- Cmb.Tech (ENXTBR:CMBT) Stock Trades At A Discount To Earnings After Vessel News Yahoo Finance · 12d ago
- Will Tanker Sale Gain Change Cmb.Tech Stock Narrative Yahoo Finance · 27d ago
- Press release: CMB.TECH fleet update Yahoo Finance · 13 Oct 2026
- Cmb.Tech (ENXTBR:CMBT) Launches Ammonia Powered Vessel, Is The Clean Shipping Upside Priced In? Yahoo Finance · 11 Oct 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $17.35 | -4.2% | · | $958 | -4.2% |
| 2 months | $20.29 | -18.1% | · | $819 | -18.1% |
| 3 months | $17.62 | -5.7% | · | $943 | -5.7% |
| 6 months | $16.16 | +2.8% | $0.64 | $1,068 | +6.8% |
| 1 year | $9.39 | +76.9% | $0.80 | $1,854 | +85.4% |
| 2 years | $12.03 | +38.2% | $0.85 | $1,452 | +45.2% |
| 3 years | $12.01 | +38.3% | $7.14 | $1,978 | +97.8% |
| 5 years | $5.40 | +207.8% | $9.92 | $4,915 | +391.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CMBT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.